Search research articles
Contact Us
Filters
Showing results (21-30 of 175) with videos related to
Page
of 18
Sort By:
Plos One
|
June 5, 2015
Joint impact of clinical and behavioral variables on the risk of unplanned readmission and death after a heart failure hospitalization
Badri Padhukasahasram, Chandan K Reddy, Yan Li, et al.
Discovery Medicine
|
April 29, 2011
Genome-wide approach to identify novel candidate genes for beta blocker response in heart failure using an experimental model
David E Lanfear, James J Yang, Sudhish Mishra, et al.
BMC Health Services Research
|
December 22, 2009
Comparing methods for identifying patients with heart failure using electronic data sources
Fadi Alqaisi, L Keoki Williams, Edward L Peterson, et al.
Current Treatment Options in Cardiovascular Medicine
|
August 28, 2016
Practical Pharmacogenomic Approaches to Heart Failure Therapeutics
Chayakrit Krittanawong, Amalia Namath, David E Lanfear, et al.
The International Journal of Artificial Organs
|
March 13, 2014
Dosing of vancomycin in patients with continuous-flow left ventricular assist devices: a clinical pharmacokinetic analysis
Douglas L Jennings, Charles T Makowski, Rachel M Chambers, et al.
International Journal of Molecular Sciences
|
May 7, 2025
Evidence of Hyperacetylation of Mitochondrial Regulatory Proteins in Left Ventricular Myocardium of Dogs with Chronic Heart Failure
Ramesh C Gupta, Kristina Szekely, Kefei Zhang, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|
February 21, 2012
Comparison of renal predictors for in-hospital and postdischarge mortality after hospitalized heart failure
Gurjit Singh, Edward L Peterson, Karen Wells, et al.
Pharmacogenomics
|
June 24, 2004
Frequency of compound genotypes associated with beta-blocker efficacy in congestive heart failure
David E Lanfear, Sharon Marsh, Sharon Cresci, et al.
Journal of Pharmacy Practice
|
December 10, 2013
Assessing the potential of e-mail for communicating drug therapy recommendations to physicians in patients with heart failure and ventricular-assist devices
Jona Lekura, Cristina Tita, David E Lanfear, et al.
Cardiovascular Drugs and Therapy
|
June 29, 2018
Abnormalities of Mitochondrial Dynamics in the Failing Heart: Normalization Following Long-Term Therapy with Elamipretide
Hani N Sabbah, Ramesh C Gupta, Vinita Singh-Gupta, et al.
Page
of 18
Search research articles
Search
Showing results (21-30 of 175) with videos related to
Sort By:
Page
of 18
Plos One
|
June 5, 2015
Joint impact of clinical and behavioral variables on the risk of unplanned readmission and death after a heart failure hospitalization
Badri Padhukasahasram, Chandan K Reddy, Yan Li, et al.
Discovery Medicine
|
April 29, 2011
Genome-wide approach to identify novel candidate genes for beta blocker response in heart failure using an experimental model
David E Lanfear, James J Yang, Sudhish Mishra, et al.
BMC Health Services Research
|
December 22, 2009
Comparing methods for identifying patients with heart failure using electronic data sources
Fadi Alqaisi, L Keoki Williams, Edward L Peterson, et al.
Current Treatment Options in Cardiovascular Medicine
|
August 28, 2016
Practical Pharmacogenomic Approaches to Heart Failure Therapeutics
Chayakrit Krittanawong, Amalia Namath, David E Lanfear, et al.
The International Journal of Artificial Organs
|
March 13, 2014
Dosing of vancomycin in patients with continuous-flow left ventricular assist devices: a clinical pharmacokinetic analysis
Douglas L Jennings, Charles T Makowski, Rachel M Chambers, et al.
International Journal of Molecular Sciences
|
May 7, 2025
Evidence of Hyperacetylation of Mitochondrial Regulatory Proteins in Left Ventricular Myocardium of Dogs with Chronic Heart Failure
Ramesh C Gupta, Kristina Szekely, Kefei Zhang, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|
February 21, 2012
Comparison of renal predictors for in-hospital and postdischarge mortality after hospitalized heart failure
Gurjit Singh, Edward L Peterson, Karen Wells, et al.
Pharmacogenomics
|
June 24, 2004
Frequency of compound genotypes associated with beta-blocker efficacy in congestive heart failure
David E Lanfear, Sharon Marsh, Sharon Cresci, et al.
Journal of Pharmacy Practice
|
December 10, 2013
Assessing the potential of e-mail for communicating drug therapy recommendations to physicians in patients with heart failure and ventricular-assist devices
Jona Lekura, Cristina Tita, David E Lanfear, et al.
Cardiovascular Drugs and Therapy
|
June 29, 2018
Abnormalities of Mitochondrial Dynamics in the Failing Heart: Normalization Following Long-Term Therapy with Elamipretide
Hani N Sabbah, Ramesh C Gupta, Vinita Singh-Gupta, et al.
Page
of 18